Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside

The incidence of type 2 (T2D) diabetes and other chronic conditions associated with insulin resistance is increasing at an alarming rate, underscoring the need for effective and safe therapeutic strategies. Peroxisome-proliferator-activated receptor gamma (PPARγ) has emerged as a critical regulator...

Descripción completa

Detalles Bibliográficos
Autores principales: Amato, Angélica Amorim, de Assis Rocha Neves, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382399/
https://www.ncbi.nlm.nih.gov/pubmed/22745632
http://dx.doi.org/10.1155/2012/978687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382399/
https://www.ncbi.nlm.nih.gov/pubmed/22745632
http://dx.doi.org/10.1155/2012/978687

Ejemplares similares